David Sandoval, Founder and Chief Science Officer of Purium, announced results from a recent study on the company’s new gut health product, Biome Medic. Studied under a randomized, product-controlled IRB- approved protocol, the six-week pre-clinical trial reported a 74% reduction of the herbicide glyphosate, a 75% reduction in the inflammatory biomarker C-reactive protein (CRP) and a 35% increase in gut immune response as measured by reduced food sensitivities.
Conducted by Florida-based Internal Medicine Specialist Matthew C. Popkin, M.D. and James Blum, Ph.D., an epidemiologist with thirty years of designing and conducting clinical trials, the study was independently assessed by Dr. Lynn Disney.
While under observation, both the experimental and control groups were requested not to change their eating habits as the control group received an active control placebo and the experimental group received Biome Medic. Subjects entered the study with a wide array of typical eating habits. After the six weeks, there was a substantial decrease of both glyphosate and the inflammatory marker CRP, both being reduced from “high / unhealthy” to “normal / healthy” levels. Specifically, the researchers noted the decrease in glyphosate and CRP levels experienced by the Biome Medic experimental group indicate a lowering of systemic inflammation which is well recognized to have positive health benefits. Elevated CRP is a strong predictor of heart disease as well as other inflammatory conditions.
Sandoval said, “Biome Medic may be an important tool in the fight against genetically-modified foods and harmful herbicides like glyphosate that have infiltrated our food supply. It is getting harder and harder to avoid these chemicals, so Biome Medic was designed to support a healthy microbiome.”